Thromboembolic Disorder in COVID-19 Infection

Authors

Shawn Lee, Department of Cardiovascular Diseases, Mount Sinai St. Luke's Icahn School of Medicine, 1111 Amsterdam Ave, New York, NY 10025, USA.
Joseph Gunderson, School of Medicine, University of Arizona College of Medicine, 1501 N Campbell Ave, Tucson, AZ 85724, USA.
Raza Mushtaq, Department of Medical Imaging, University of Arizona College of Medicine, 1501 N Campbell Ave, Tucson, AZ 85724, USA.Follow

Document Type

Article

Abstract

Coronavirus (COVID-19) is a global pandemic with over 600 million cases identified. In addition to extensive pulmonary complications of COVID-19, one feature unique to many patients with severe COVID-19 infections is coagulopathy with a rising prevalence of multi-systemic thromboembolic manifestations. Global data suggests a relationship between coagulopathy and mortality. In this review, we highlight multiple COVID-19 thromboembolic complications with emphasis on pathophysiology, clinical management, and radiological manifestations.

Medical Subject Headings

Humans; COVID-19; SARS-CoV-2; Blood Coagulation Disorders (epidemiology, etiology)

Publication Date

1-1-2023

Publication Title

Current medical imaging

E-ISSN

1573-4056

Volume

19

Issue

14

First Page

1616

Last Page

1627

PubMed ID

36797601

Digital Object Identifier (DOI)

10.2174/1573405619666230216112751

Recommended Citation

Lee, Shawn; Gunderson, Joseph; and Mushtaq, Raza, "Thromboembolic Disorder in COVID-19 Infection" (2023). Neuroradiology. 76.
https://scholar.barrowneuro.org/neuroradiology/76